Supernus Pharmaceuticals Other Operating Income or Expenses 2011-2024 | SUPN
Supernus Pharmaceuticals other operating income or expenses from 2011 to 2024. Other operating income or expenses can be defined as the aggregate amount of all operating expenses either too small to report separately or that cannot be standardized into another Zacks field.
Supernus Pharmaceuticals Annual Other Operating Income or Expenses
(Millions of US $) |
| 2023 |
$-19 |
| 2022 |
$1 |
| 2021 |
$7 |
| 2020 |
$-2 |
| 2019 |
$ |
| 2018 |
$0 |
| 2017 |
$ |
| 2016 |
$ |
| 2015 |
$ |
| 2014 |
$ |
| 2013 |
$ |
| 2012 |
$ |
| 2011 |
$ |
| 2010 |
$ |
Supernus Pharmaceuticals Quarterly Other Operating Income or Expenses
(Millions of US $) |
| 2024-06-30 |
$4 |
| 2024-03-31 |
$1 |
| 2023-12-31 |
$-20 |
| 2023-09-30 |
$0 |
| 2023-06-30 |
$-1 |
| 2023-03-31 |
$2 |
| 2022-12-31 |
$2 |
| 2022-09-30 |
$-0 |
| 2022-06-30 |
$-1 |
| 2022-03-31 |
$-1 |
| 2021-12-31 |
$-1 |
| 2021-09-30 |
$-0 |
| 2021-06-30 |
$9 |
| 2021-03-31 |
$-1 |
| 2020-12-31 |
$-2 |
| 2020-09-30 |
$-0 |
| 2020-06-30 |
|
| 2020-03-31 |
$0 |
| 2019-12-31 |
|
| 2019-09-30 |
|
| 2019-06-30 |
|
| 2019-03-31 |
|
| 2018-12-31 |
|
| 2018-09-30 |
|
| 2018-06-30 |
|
| 2018-03-31 |
|
| 2017-12-31 |
|
| 2017-09-30 |
|
| 2017-06-30 |
|
| 2017-03-31 |
|
| 2016-12-31 |
|
| 2016-09-30 |
|
| 2016-06-30 |
|
| 2016-03-31 |
|
| 2015-12-31 |
|
| 2015-09-30 |
|
| 2015-06-30 |
|
| 2015-03-31 |
|
| 2014-12-31 |
|
| 2014-09-30 |
|
| 2014-06-30 |
|
| 2014-03-31 |
|
| 2013-12-31 |
|
| 2013-09-30 |
|
| 2013-06-30 |
|
| 2013-03-31 |
|
| 2012-12-31 |
|
| 2012-09-30 |
|
| 2012-06-30 |
|
| 2012-03-31 |
|
| 2011-12-31 |
|
| 2011-09-30 |
|
| 2011-06-30 |
|
| 2011-03-31 |
|
| 2010-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$2.022B |
$0.608B |
|
Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. It is developing several product candidates in neurology and psychiatry to address opportunities in epilepsy and attention deficit hyperactivity disorder. Supernus Pharmaceuticals Inc. is based in Rockville, Maryland.
|
